BE667158A - - Google Patents

Info

Publication number
BE667158A
BE667158A BE667158A BE667158A BE667158A BE 667158 A BE667158 A BE 667158A BE 667158 A BE667158 A BE 667158A BE 667158 A BE667158 A BE 667158A BE 667158 A BE667158 A BE 667158A
Authority
BE
Belgium
Application number
BE667158A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE667158A publication Critical patent/BE667158A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00—Photosensitive materials
    • G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/06—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
    • G03C1/34—Fog-inhibitors; Stabilisers; Agents inhibiting latent image regression
BE667158A 1964-07-20 1965-07-20 BE667158A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38396364A 1964-07-20 1964-07-20

Publications (1)

Publication Number Publication Date
BE667158A true BE667158A (en) 1965-11-16

Family

ID=23515488

Family Applications (1)

Application Number Title Priority Date Filing Date
BE667158A BE667158A (en) 1964-07-20 1965-07-20

Country Status (2)

Country Link
US (1) US3499761A (en)
BE (1) BE667158A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6329355B1 (en) 1997-01-28 2001-12-11 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6362207B1 (en) 1995-04-12 2002-03-26 The Procter & Gamble Company Methods of treating viral infections with benzimidazoles
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6420411B1 (en) 1997-05-16 2002-07-16 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655391A (en) * 1969-05-16 1972-04-11 Paoli Merli Azodicarbonamide fog inhibitors
GB1494741A (en) * 1974-03-14 1977-12-14 Agfa Gevaert Fog-inhibitors for silver halide photography
US4131467A (en) * 1977-11-23 1978-12-26 E. I. Du Pont De Nemours And Company 4,7-Dihydroxybenzimidazole hydrobromide as antifogger
US4572892A (en) * 1984-05-21 1986-02-25 Eastman Kodak Company Direct positive photographic elements with incorporated maximum density enhancing antifoggants
AU2001257325A1 (en) * 2000-04-28 2001-11-12 The Procter And Gamble Company Cancer treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023103A (en) * 1960-08-02 1962-02-27 Gen Aniline & Film Corp Antifoggants and stabilizers for photographic silver halide emulsions
US3271154A (en) * 1961-11-30 1966-09-06 Gen Aniline & Film Corp Antifogging and stabilizing agents for photography
BE628098A (en) * 1962-02-07
US3255202A (en) * 1963-08-23 1966-06-07 Union Carbide Corp Process for the preparation of 2-(acylamidoalkyl)benzimidazoles

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6362207B1 (en) 1995-04-12 2002-03-26 The Procter & Gamble Company Methods of treating viral infections with benzimidazoles
US6653335B2 (en) 1995-04-12 2003-11-25 University Of Arizona Foundationa Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6552059B2 (en) 1995-06-07 2003-04-22 University Of Arizona Foundation Pharmaceutical composition for and method of treating leukemia
US6329355B1 (en) 1997-01-28 2001-12-11 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6482843B1 (en) 1997-05-16 2002-11-19 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6864275B1 (en) 1997-05-16 2005-03-08 Uaf Technologies And Research, Llc Compounds and methods for use thereof in the treatment of cancer
US6423736B1 (en) 1997-05-16 2002-07-23 The Proctor & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6423735B1 (en) 1997-05-16 2002-07-23 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6984654B2 (en) 1997-05-16 2006-01-10 Uaf Technologies And Research, Llc Cancer treatments and pharmaceutical compositions therefor
US6420411B1 (en) 1997-05-16 2002-07-16 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6900235B1 (en) 1997-05-16 2005-05-31 Uaf Technologies And Research, Llc Benzimidazole compounds, and pharmaceutical compositions and unit dosages thereof
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6710065B1 (en) 1997-05-16 2004-03-23 Uaf Technologies And Research, Llc Compounds and methods for use thereof in the treatment of cancer
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6906091B2 (en) 1999-08-13 2005-06-14 Uaf Technologies And Research, Llc Method of cancer treatment
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6720349B2 (en) 2000-09-26 2004-04-13 Uaf Technologies And Research, Llc Compounds for use in the treatment of cancer or viral infections
US6916836B2 (en) 2000-09-26 2005-07-12 Uaf Technologies And Research, Llc Compounds and methods for use thereof in the treatment of viral infections
US6930121B2 (en) 2000-09-26 2005-08-16 Uaf Technologies And Research, Llc Compounds and methods for use thereof in the treatment of viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections

Also Published As

Publication number Publication date
US3499761A (en) 1970-03-10

Similar Documents

Publication Publication Date Title
BE642104A (en)
BE642530A (en)
BE660893A (en)
BE660664A (en)
BE660036A (en)
BE659730A (en)
BE659234A (en)
BE622126A (en)
BE659170A (en)
BE658332A (en)
BE658266A (en)
BE658146A (en)
BE657664A (en)
BE657382A (en)
BE667158A (en)
BE655918A (en)
BE655415A (en)
BE652455A (en)
BE650355A (en)
BE646151A (en)
BE642973A (en)
BE642797A (en)
BE642770A (en)
BE642212A (en)
BE642735A (en)